Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels

Aim. To evaluate 5-year major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) and high lipoprotein(a) (Lp(a)) levels in the Uzbek population.Material and methods. The study included 216 patients (96 men and 120 women) hospitalized with a diagnosis of "CAD. Pr...

Full description

Saved in:
Bibliographic Details
Main Authors: R. B. Alieva, A. B. Shek, A. A. Abdullaev, H. G. Fozilov, Sh. U. Khoshimov, G. D. Abdullaeva, D. Zakirova, L. E. Kan, A. R. Kim, R. A. Kurbanova, D. B. Yusupalieva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2025-04-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/6019
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839576498782076928
author R. B. Alieva
A. B. Shek
A. A. Abdullaev
H. G. Fozilov
Sh. U. Khoshimov
G. D. Abdullaeva
D. Zakirova
L. E. Kan
A. R. Kim
R. A. Kurbanova
D. B. Yusupalieva
author_facet R. B. Alieva
A. B. Shek
A. A. Abdullaev
H. G. Fozilov
Sh. U. Khoshimov
G. D. Abdullaeva
D. Zakirova
L. E. Kan
A. R. Kim
R. A. Kurbanova
D. B. Yusupalieva
author_sort R. B. Alieva
collection DOAJ
description Aim. To evaluate 5-year major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) and high lipoprotein(a) (Lp(a)) levels in the Uzbek population.Material and methods. The study included 216 patients (96 men and 120 women) hospitalized with a diagnosis of "CAD. Progressive angina", in whom MACE (cardiovascular death, non-fatal myocardial infarction and stroke) was assessed during 5 years of follow-up. The 2-∆∆Сt value, correlating with the number of LPA KIV-2 repeats, was determined in genomic DNA using quantitative real-time polymerase chain reaction (qPCR).Results. In patients with CAD with elevated Lp(a) in the quartile 4 ≥48 mg/dL, the MACE risk was 2 times higher (relative risk 2,0; 95% confidence interval 1,04-3,87, P<0,05) than in quartile 1 ≤6 mg/dl. Moreover, among men it was 2,6 times higher (P<0,05), while in women — 1,4 times higher without significant difference. In contrast, in the study cohort, the MACE risk in quartile 1 <3,9 of 2-∆∆Сt was 3 times higher than in quartile 4 (>6) (P<0,01) in men, and 3,3 times higher among women (P<0,05). Lp(a) concentration in the examined subjects was inversely dependent on the 2-∆∆Сt value. We also observed a decreased MACE risk in women with high Apolipoprotein A-I (apoA) levels in quartile 4 (>175 mg/dL) versus quartile 1 (<140 mg/dL) with relative risk of 0,30 (95% confidence interval 0,10-0,98, P<0,05).Conclusion. The 2-∆∆Сt value in the lower quartile associated with a low number of LPA KIV-2 repeats more accurately reflects the MACE risk in women with CAD. Also, the relative risk in women was lower in the upper quartile of apoA compared to the lower one.
format Article
id doaj-art-a2e9fbcfa3334e858bdba91d43cae6ad
institution Matheson Library
issn 1560-4071
2618-7620
language Russian
publishDate 2025-04-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-a2e9fbcfa3334e858bdba91d43cae6ad2025-08-04T13:00:35Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202025-04-0130310.15829/1560-4071-2025-60194167Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levelsR. B. Alieva0A. B. Shek1A. A. Abdullaev2H. G. Fozilov3Sh. U. Khoshimov4G. D. Abdullaeva5D. Zakirova6L. E. Kan7A. R. Kim8R. A. Kurbanova9D. B. Yusupalieva10Republican Specialized Scientific and Practical Medical Center of CardiologyRepublican Specialized Scientific and Practical Medical Center of CardiologyCenter for Advanced TechnologiesRepublican Specialized Scientific and Practical Medical Center of CardiologyRepublican Specialized Scientific and Practical Medical Center of CardiologyRepublican Specialized Scientific and Practical Medical Center of CardiologyCenter for Advanced TechnologiesRepublican Specialized Scientific and Practical Medical Center of CardiologyRepublican Specialized Scientific and Practical Medical Center of CardiologyRepublican Specialized Scientific and Practical Medical Center of CardiologyRepublican Specialized Scientific and Practical Medical Center of CardiologyAim. To evaluate 5-year major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) and high lipoprotein(a) (Lp(a)) levels in the Uzbek population.Material and methods. The study included 216 patients (96 men and 120 women) hospitalized with a diagnosis of "CAD. Progressive angina", in whom MACE (cardiovascular death, non-fatal myocardial infarction and stroke) was assessed during 5 years of follow-up. The 2-∆∆Сt value, correlating with the number of LPA KIV-2 repeats, was determined in genomic DNA using quantitative real-time polymerase chain reaction (qPCR).Results. In patients with CAD with elevated Lp(a) in the quartile 4 ≥48 mg/dL, the MACE risk was 2 times higher (relative risk 2,0; 95% confidence interval 1,04-3,87, P<0,05) than in quartile 1 ≤6 mg/dl. Moreover, among men it was 2,6 times higher (P<0,05), while in women — 1,4 times higher without significant difference. In contrast, in the study cohort, the MACE risk in quartile 1 <3,9 of 2-∆∆Сt was 3 times higher than in quartile 4 (>6) (P<0,01) in men, and 3,3 times higher among women (P<0,05). Lp(a) concentration in the examined subjects was inversely dependent on the 2-∆∆Сt value. We also observed a decreased MACE risk in women with high Apolipoprotein A-I (apoA) levels in quartile 4 (>175 mg/dL) versus quartile 1 (<140 mg/dL) with relative risk of 0,30 (95% confidence interval 0,10-0,98, P<0,05).Conclusion. The 2-∆∆Сt value in the lower quartile associated with a low number of LPA KIV-2 repeats more accurately reflects the MACE risk in women with CAD. Also, the relative risk in women was lower in the upper quartile of apoA compared to the lower one.https://russjcardiol.elpub.ru/jour/article/view/6019high lipoprotein(a) levelquantitative real-time pcrcoronary artery diseasemajor cardiovascular eventssex differences
spellingShingle R. B. Alieva
A. B. Shek
A. A. Abdullaev
H. G. Fozilov
Sh. U. Khoshimov
G. D. Abdullaeva
D. Zakirova
L. E. Kan
A. R. Kim
R. A. Kurbanova
D. B. Yusupalieva
Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels
Российский кардиологический журнал
high lipoprotein(a) level
quantitative real-time pcr
coronary artery disease
major cardiovascular events
sex differences
title Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels
title_full Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels
title_fullStr Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels
title_full_unstemmed Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels
title_short Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels
title_sort sex differences in 5 year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein a levels
topic high lipoprotein(a) level
quantitative real-time pcr
coronary artery disease
major cardiovascular events
sex differences
url https://russjcardiol.elpub.ru/jour/article/view/6019
work_keys_str_mv AT rbalieva sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels
AT abshek sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels
AT aaabdullaev sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels
AT hgfozilov sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels
AT shukhoshimov sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels
AT gdabdullaeva sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels
AT dzakirova sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels
AT lekan sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels
AT arkim sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels
AT rakurbanova sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels
AT dbyusupalieva sexdifferencesin5yearriskofmajoradversecardiovasculareventsinpatientswithcoronaryarterydiseaseandelevatedlipoproteinalevels